NASDAQ:APYX Apyx Medical (APYX) Stock Price, News & Analysis $2.40 +0.01 (+0.42%) Closing price 04:00 PM EasternExtended Trading$2.40 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Apyx Medical Stock (NASDAQ:APYX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Apyx Medical alerts:Sign Up Key Stats Today's Range$2.35▼$2.4650-Day Range$2.36▼$3.0652-Week Range$2.25▼$5.08Volume100,119 shsAverage Volume143,564 shsMarket Capitalization$101.09 millionP/E RatioN/ADividend YieldN/APrice Target$6.20Consensus RatingModerate Buy Company Overview Apyx Medical Corporation is a medical technology company focused on advanced energy devices for surgical and aesthetic procedures. Its main product is the Renuvion system, which combines helium plasma with radiofrequency energy for use in procedures covered by applicable regulatory clearances. The company also supplies electrosurgical generators and related products, including through its original equipment manufacturing business. Apyx Medical was formerly known as Bovie Medical Corporation and adopted its current name in 2018. Based in Clearwater, Florida, Apyx Medical serves customers in the United States and international markets, including through distribution partners.AI Generated. May Contain Errors. Read More Apyx Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreAPYX MarketRank™: 2.487667854205 of 5 starsApyx Medical scored higher than 50% of companies evaluated by MarketBeat, and ranked 484th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.8 / 5Analyst RatingModerate Buy Consensus RatingApyx Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on 1 strong buy rating, 4 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialApyx Medical has a consensus price target of $6.20, representing about 157.3% upside from its current price of $2.41.Amount of Analyst CoverageApyx Medical has only been the subject of 2 research reports in the past 90 days.Read more about Apyx Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Apyx Medical are expected to decrease in the coming year, from ($0.21) to ($0.22) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Apyx Medical is -12.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Apyx Medical is -12.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApyx Medical has a P/B Ratio of 10.04. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.69% of the float of Apyx Medical has been sold short.Short Interest Ratio / Days to CoverApyx Medical has a short interest ratio ("days to cover") of 2.08, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Apyx Medical has recently increased by 14.83%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldApyx Medical does not currently pay a dividend.Dividend GrowthApyx Medical does not have a long track record of dividend growth. News and Social Media2.6 / 5News SentimentN/A News SentimentApyx Medical has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.40 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Apyx Medical this week, compared to 3 articles on an average week. Company Ownership1.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Apyx Medical insiders have not sold or bought any company stock.Percentage Held by Insiders15.90% of the stock of Apyx Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions55.33% of the stock of Apyx Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Apyx Medical's insider trading history. Receive APYX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. APYX Stock News HeadlinesHC Wainwright Expects Stronger Earnings for Apyx MedicalNovember 12, 2026 | americanbankingnews.comTranscript : Apyx Medical Corporation Presents at 2026 UBS Global Healthcare Conference, Nov-09-2026 10:15 AMNovember 9, 2026 | marketscreener.comMA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.November 20 at 1:00 AM | Behind the Markets (Ad)Apyx Medical Corporation (APYX) Presents at 2026 UBS Global Healthcare Conference TranscriptNovember 9, 2026 | seekingalpha.comMaxim Group Remains a Buy on Apyx Medical (APYX)November 8, 2026 | theglobeandmail.comApyx Medical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 7, 2026 | marketscreener.comMTranscript : Apyx Medical Corporation, Q3 2026 Earnings Call, Nov 05, 2026November 5, 2026 | marketscreener.comMApyx reaffirms 2026 revenue guidance of $59M-$60M while tightening operating expense target to $41M-$42.5MNovember 5, 2026 | seekingalpha.comSee More Headlines APYX Stock Analysis - Frequently Asked Questions How have APYX shares performed this year? Apyx Medical's stock was trading at $3.50 on January 1st, 2026. Since then, APYX shares have decreased by 31.1% and is now trading at $2.41. How were Apyx Medical's earnings last quarter? Apyx Medical Corporation (NASDAQ:APYX) announced its quarterly earnings data on Thursday, November, 5th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.09) by $0.05. The business had revenue of $14.03 million for the quarter, compared to analyst estimates of $13.29 million. Apyx Medical had a negative net margin of 14.16% and a negative trailing twelve-month return on equity of 68.79%. Read the conference call transcript. Who are Apyx Medical's major shareholders? Apyx Medical's top institutional shareholders include Royce & Associates LP (8.32%), Nantahala Capital Management LLC (7.94%), Kanen Wealth Management LLC (3.68%) and Horizon Kinetics Asset Management LLC (1.09%). View institutional ownership trends. How do I buy shares of Apyx Medical? Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Apyx Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Apyx Medical investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Alibaba Group (BABA), Block (XYZ), Bovie Medical (BVX), Tesla (TSLA) and AbbVie (ABBV). Company Calendar Last Earnings11/05/2026Today11/20/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (4d) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 As of 4 days ago, APYX's financial health entered the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:APYX CIK719135 Webwww.apyxmedical.com Phone(727) 384-2323Fax800-323-1640Employees205Year Founded1982Price Target and Rating Average Price Target for Apyx Medical$6.20 High Price Target$7.00 Low Price Target$6.00 Potential Upside/Downside+158.3%Consensus RatingModerate Buy Rating Score (0-4)2.71 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($0.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$11.21 million Net Margins-14.16% Pretax Margin-13.07% Return on Equity-68.79% Return on Assets-13.36% Debt Debt-to-Equity Ratio3.54 Current Ratio4.95 Quick Ratio3.85 Sales & Book Value Annual Sales$52.84 million Price / Sales1.91 Cash FlowN/A Price / Cash FlowN/A Book Value$0.24 per share Price / Book10.00Miscellaneous Outstanding Shares42,120,000Free Float35,426,000Market Cap$101.09 million OptionableOptionable Beta1.47 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:APYX) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | Sponsored6 Men Secretly Changed America’s Money. Now It’s Happening AgainIn 1910, six powerful men secretly met to lay the groundwork for the Federal Reserve, reshaping America's fina...Banyan Hill Publishing | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Apyx Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.